FDA Commissioner Marty Makary Resigns After Turbulent Tenure

Marty Makary stepped down as commissioner of the U.S. Food and Drug Administration on Tuesday, ending a period marked by controversy and intense scrutiny.

His resignation follows a series of public disagreements and policy debates that have drawn criticism from industry groups and lawmakers.

The agency now faces uncertainty about its leadership direction as senior officials prepare to manage ongoing regulatory work.

Analysts note that the change could affect the timing of pending drug approvals and enforcement actions, though no immediate policy shifts have been announced.